Related Experiment Video
Updated: Mar 10, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation
Published on: January 17, 2011
Insights
Preventable adverse events (AEs) harm patients, but disclosure is hindered by liability fears. Legal reforms, better communication, and disclosure programs can improve reporting of AEs.
Area of Science:
- Medical Ethics
- Patient Safety
- Health Law
Background:
- Preventable adverse events (AEs) remain a significant concern in healthcare, leading to patient, family, and provider harm.
- Pediatricians recognize an ethical duty to disclose AEs and medical errors to patients and families.
- Fear of legal liability is a major barrier to the open disclosure of AEs.
Purpose of the Study:
- To explore the ethical obligation and practical barriers to disclosing preventable adverse events (AEs) in pediatrics.
- To identify strategies for improving the quality and frequency of AE disclosure communications.
Main Methods:
- Literature review on patient safety, medical ethics, and disclosure policies.
- Analysis of legal and communication barriers impacting AE reporting.
- Examination of proposed solutions including legal system changes and communication training.
Main Results:
- Ethical imperatives for disclosure are widely accepted by pediatricians.
- Legal concerns, particularly liability, significantly impede disclosure practices.
- Effective disclosure requires a multi-faceted approach.
Conclusions:
- Improving AE disclosure necessitates addressing legal barriers and enhancing communication skills.
- Development of robust disclosure policies and programs is crucial for patient safety.
- Systemic changes in the legal and communication frameworks can foster more transparent reporting of adverse events.
Abstract:
Despite increasing attention to issues of patient safety, preventable adverse events (AEs) continue to occur, causing direct and consequential injuries to patients, families, and health care providers. Pediatricians generally agree that there is an ethical obligation to inform patients and families about preventable AEs and medical errors. Nonetheless, barriers, such as fear of liability, interfere with disclosure regarding preventable AEs. Changes to the legal system, improved communications skills, and carefully developed disclosure policies and programs can improve the quality and frequency of appropriate AE disclosure communications.
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmaceutical Poisoning: Potential Scenarios
Types of Reports II: Incident or Occurrence Report
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

